Cargando…
Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development
BACKGROUND: Because of the highly heterogeneous nature of breast cancer, each subtype differs in response to several treatment regimens. This has limited the therapeutic options for metastatic breast cancer disease requiring exploration of diverse therapeutic models to target tumor specific biomarke...
Autores principales: | Altaf, Reem, Nadeem, Humaira, Babar, Mustafeez Mujtaba, Ilyas, Umair, Muhammad, Syed Aun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885587/ https://www.ncbi.nlm.nih.gov/pubmed/33593445 http://dx.doi.org/10.1186/s40709-021-00136-7 |
Ejemplares similares
-
Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach
por: Ilyas, Umair, et al.
Publicado: (2020) -
Correction to: Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach
por: Ilyas, Umair, et al.
Publicado: (2020) -
Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
por: Afzaal, Hasan, et al.
Publicado: (2022) -
Synthesis, Biological Evaluation, 2D-QSAR, and Molecular
Simulation Studies of Dihydropyrimidinone Derivatives as Alkaline
Phosphatase Inhibitors
por: Altaf, Reem, et al.
Publicado: (2022) -
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022)